Remote home care company Biofourmis tipped its Series D round to $320 million with a $20 million extension from Intel Capital, the investment arm of chipmaker Intel.
Driving the news: Health care has moved beyond the four walls of the hospital, fueled by a combination of the pandemic, cost-cutting measures and rapidly changing patient and provider preferences.
